NCT01819701View on ClinicalTrials.gov

L-carnitine and Coenzyme Q10 in Relation to the Oxidative Stress, Antioxidant Enzymes Activities, Inflammation, and the Risk of Coronary Artery Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Coronary Artery Disease
Interventions
DIETARY_SUPPLEMENT

LC-1000

L-carnitine 1000 mg /d

DIETARY_SUPPLEMENT

LC-2000

L-carnitine: 2000 mg/d

DIETARY_SUPPLEMENT

Q10-150

Coenzyme Q10: 150 mg/d

DIETARY_SUPPLEMENT

Q10-300

Coenzyme Q10: 300 mg/d

OTHER

Placebo

Trial Locations (1)

40705

Taichung Verterans General Hospital, Taichung

All Listed Sponsors
lead

Taichung Veterans General Hospital

OTHER

NCT01819701 - L-carnitine and Coenzyme Q10 in Relation to the Oxidative Stress, Antioxidant Enzymes Activities, Inflammation, and the Risk of Coronary Artery Disease | Biotech Hunter | Biotech Hunter